2014
DOI: 10.1136/ejhpharm-2013-000436.191
|View full text |Cite
|
Sign up to set email alerts
|

DI-020 Patient-reported outcomes during prophylaxis with inhaled antibiotics for fibrosis bronchiectasis

Abstract: Background Inhaled antibiotics are increasingly used in patients with non-cystic fibrosis bronchiectasis as off-label treatment, without quantifiable effectiveness. Patients’perspective is an important part of healthcare quality. Due to internal procedures the pharmacy service supervises off-label treatments. Purpose To explore in a group of patients suffering from bronchiectasis, their perception of their last year and their current health status. Materials and methods Prospective study based on a survey … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles